| scholarly article | Q13442814 |
| P2093 | author name string | Qiang Wang | |
| Liang Song | |||
| Bin Jiang | |||
| Xiangyan Liu | |||
| Mo Shi | |||
| Zhongwei Xin | |||
| Gongsun Xin | |||
| P2860 | cites work | Mucins in cancer: function, prognosis and therapy | Q24633765 |
| Cancer statistics, 2008 | Q27860585 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target | Q28547180 | ||
| The landscape of somatic copy-number alteration across human cancers | Q29547648 | ||
| MYC on the path to cancer | Q29619979 | ||
| Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: its relationship with prognosis | Q77889701 | ||
| Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities | Q33612658 | ||
| MUC1: a multifaceted oncoprotein with a key role in cancer progression | Q33880143 | ||
| Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Q34374229 | ||
| Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoprotein | Q34555770 | ||
| Modelling Myc inhibition as a cancer therapy | Q34811008 | ||
| Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells | Q34970672 | ||
| Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C. | Q35658479 | ||
| Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells | Q35888913 | ||
| CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1. | Q36370199 | ||
| Conditional transgenic models define how MYC initiates and maintains tumorigenesis | Q36578360 | ||
| MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches | Q36753508 | ||
| Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities | Q36836275 | ||
| Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells | Q37290260 | ||
| An overview of MYC and its interactome | Q37406278 | ||
| MUC1 oncoprotein is a druggable target in human prostate cancer cells | Q37437966 | ||
| Molecular Pathways: Targeting MYC-induced metabolic reprogramming and oncogenic stress in cancer. | Q38125169 | ||
| Myc and cell cycle control. | Q38202390 | ||
| MUC1 induces metastasis in esophageal squamous cell carcinoma by upregulating matrix metalloproteinase 13. | Q38337165 | ||
| Induction of apoptosis by eicosapentaenoic acid in esophageal squamous cell carcinoma | Q38928878 | ||
| MUC1-C Oncoprotein Integrates a Program of EMT, Epigenetic Reprogramming and Immune Evasion in Human Carcinomas | Q39182659 | ||
| Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62. | Q40133198 | ||
| Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development | Q43512505 | ||
| MUC1-C is a target in lenalidomide resistant multiple myeloma | Q46345708 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | esophageal squamous cell carcinoma | Q108442577 |
| P304 | page(s) | 4125-4136 | |
| P577 | publication date | 2018-07-19 | |
| P1433 | published in | OncoTargets and Therapy | Q7092081 |
| P1476 | title | Inhibition of MUC1-C entering nuclear suppresses MYC expression and attenuates malignant growth in esophageal squamous cell carcinoma. | |
| P478 | volume | 11 |
Search more.